The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines
SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ — ImmunoSc… […]
CARLSBAD, Calif., Aug. 2, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $1… […]
Conference call scheduled for 4:30 p.m. ET today- Enrollment Continues in Phase 2b VOYAGE Study of VK2809 in NASH; New Data from 12-Week Phase 2 Trial to be Highlighted at EASL- IND Filed for VK0214 in X-ALD; Phase 1 Trial Expected to Begin Q3 2020- Ba… […]
CARLSBAD, Calif., July 13, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), announced that today Chief Executive Officer Michael Poirier has issued a letter to Qualigen’s stockholders. The full text of t… […]
Company Focused on Finding an Effective Solution for Acute Kidney Injury (AKI)
CARLSBAD, Calif., May 28, 2020 /PRNewswire/ — Venture.co Brokerage Services, LLC (“VENTURE.co”) today announces a private capital investment opportunity into HemaFlo Ther… […]
– Funding will also enable the addition of new trial sites to accelerate completion of the Phase 2 clinical trial- Data continues to demonstrate the safety and efficacy of onvansertib as a promising new treatment for patients with KRAS-mutated mCRC
S… […]
SAN DIEGO, April 28, 2020 /PRNewswire/ –?Sweetwater Investment Management (“Sweetwater” or “Sweetwater Private Equity” (dba)) announced during their recent annual investor meeting the selection of Chad Robins, CEO of Adaptive Biotechnologies Corp. … […]
SAN DIEGO, April 1, 2020 /PRNewswire/ — Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson disease, today announced the close of its Series A funding round of $70 millio… […]
POWAY, Calif., March 20, 2020 /PRNewswire/ — With cases of coronavirus COVID-19 disease rising at an unprecedented rate, CTK has taken their proven strength in developing infectious disease diagnostics and in collaboration with its partners in Chin… […]